London, United Kingdom (4E) – A group of U.K. parliamentarians want to introduce a law requiring all alcoholic drinks in the country to include a health warning and nutritional content in their labels.
The proposal is one of 10 the All-Party Parliamentary Group on Alcohol Misuse (APPG) wants colleagues to support to lower the number of Britons hospitalized for alcohol abuse and liver disease related to alcohol addiction.
“Consumer information on alcohol products usually extends no further than the volume strength and unit content,” APPG stated in its Manifesto 2015. “In order to inform consumers about balanced risk, every alcohol label should include an evidence-based health warning as well as describing the product’s nutritional calorific and alcohol content.”
About1.2 million people a year are admitted to hospital due to alcohol while liver disease among adults under 30 has more than doubled over the past 10 years, according to the group. The problem impacts the national economy to the tune of $35 million, APPG said.
Other proposals of APPG are a minimum unit price on alcohol, stronger marketing regulations to protect the young, increased funding for treatment, making public health a core licensing objective, a single government minister responsible or accountable for alcohol harms, and mandatory training in parental substance misuse for all healthcare professionals and social workers.
“Getting political parties to seriously commit to these ten measures will be a massive step in tackling the huge public health issue that alcohol is,” The Guardian quoted APPG chairman MP Tracey Crouch as saying.
In the U.S., alcoholic beverage labeling indicating serving size, servings per container, calories, carbohydrates, protein and fat per serving is voluntary for beer, wine and spirits makers. The Treasury Department’s Alcohol and Tobacco Trade and Tax Bureau (TTB) issued the policy in May.
Excessive drinking has resulted in around 88,000 deaths in the U.S., according to data from the Centers for Disease Control and Prevention (CDC). One in 10 deaths is an employed adult between the ages of 20 and 64. The cost of the problem is approximately $223.5 billion in 2006.
“The numbers continue to be staggering. It’s not a great revelation to say more emphasis is needed on prevention campaigns,” said BioCorRx, Inc. (OTCQB: BICX) Chief Operating Officer Brady Grainier in an interview.
BioCorRx, Inc. is one of the fastest growing companies in the substance abuse addiction treatment sector in the U.S. It is the developer of the Start Fresh Program used in addiction clinics nationwide.
The two-phased program involves the use of biodegradable naltrexone implant by patients. The implant delivers therapeutic levels of the antagonist drug naltrexone into the bloodstream to curb cravings for alcohol or opioids.
The second part of the program involves a private, one-on-one coaching program to address the specific needs of the individual and to help him or her plan for a life free from substance abuse.
For more information on BioCorRx, Inc.’s Start Fresh Program, you may reach the company’s headquarters via phone: 714-462-4880, or email: info@BioCorRx.com.